Work

Proline-Rich Tyrosine Kinase (Pyk2) Promotes Tumor Progression in Multiple Myeloma (MM) and Represents a Novel Target for Therapy in MM

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.2101.2101

Authors: Yu Zhang, Yong Zhang, Yuji Mishima, Michele Moschetta, Wenjing Zhang, Patricia Maiso, Antonio Sacco, Yosra Aljawai, Ilyas Sahin, Michaela R. Reagan, Jennifer E. Ring, Winnie F. Tam, Qunli Xu, Jonathan A. Pachter, Aldo M Roccaro, Irene M. Ghobrial

Institutions: Harvard University, Dana-Farber Cancer Institute, Verastem (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2553787234

FWCI:

Cites:

Cited by:

Related to: 10